Genmark Diagnostics Inc股价飙升29.03% 市值涨5.06亿美元

自选股智能写手2021-03-15

北京时间2021年03月15日21时31分，Genmark Diagnostics Inc（GNMK.us）股票出现异动，股价急速上涨29.03%。截至发稿，该股报23.87美元/股，成交量715.309万股，换手率9.79%，振幅0.16%。最近的财报数据显示，该股实现营业收入1.72亿美元，净利润-18.64百万美元，每股收益-0.28美元，毛利67.94百万美元，市盈率-85.25倍。机构...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2119948448?lang=zh_CN&edition=full","thumbnail":"https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36","is_english":false,"pubTime":"2021-03-15 21:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2119948448","market":"us","top_or_hot":-1,"title":"Genmark Diagnostics Inc股价飙升29.03% 市值涨5.06亿美元","media":"自选股智能写手","content":"<div>\n<p>北京时间2021年03月15日21时31分，Genmark Diagnostics Inc（GNMK.us）股票出现异动，股价急速上涨29.03%。截至发稿，该股报23.87美元/股，成交量715.309万股，换手率9.79%，振幅0.16%。最近的财报数据显示，该股实现营业收入1.72亿美元，净利润-18.64百万美元，每股收益-0.28美元，毛利67.94百万美元，市盈率-85.25倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021031521312379b6a4b4&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Genmark Diagnostics Inc股价飙升29.03% 市值涨5.06亿美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nGenmark Diagnostics Inc股价飙升29.03% 市值涨5.06亿美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-03-15 21:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021031521312379b6a4b4&s=b><strong>自选股智能写手</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2021年03月15日21时31分，Genmark Diagnostics Inc（GNMK.us）股票出现异动，股价急速上涨29.03%。截至发稿，该股报23.87美元/股，成交量715.309万股，换手率9.79%，振幅0.16%。最近的财报数据显示，该股实现营业收入1.72亿美元，净利润-18.64百万美元，每股收益-0.28美元，毛利67.94百万美元，市盈率-85.25倍。机构...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021031521312379b6a4b4&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"CGEM","symbol_name":"Cullinan Therapeutics","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021031521312379b6a4b4&s=b","article_id":"2119948448","we_media_id":null,"thumbnails":["https://static.tigerbbs.com/480431b5715196c0e96044cc36788e36"],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2021031521312379b6a4b4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2119948448","pubTimestamp":1615815083,"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2021年03月15日21时31分，Genmark Diagnostics Inc股票出现异动，股价急速上涨29.03%。Genmark Diagnostics Inc股票所在的医疗器械行业中，整体涨幅为0.56%。消息层面，截至21时31分，《罗氏：将以18亿美元收购美国分子诊断测试制造商Genmark Diagnostics》资讯为影响Genmark Diagnostics Inc的重要信息。罗氏表示，将发起收购要约，以全现金交易方式全面收购Genmark，价格为每股24.05美元，较Genmark 2月10日的收盘价溢价43%。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"CGEM":"Cullinan Therapeutics","GNMK":"GenMark Diagnostics","SANA":"Sana Biotechnology, Inc.","LHDX":"Lucira Health, Inc.","APR":"Apria, Inc.","LABP":"Landos Biopharma, Inc."},"translate_title":"Genmark Diagnostics Inc. shares soared 29.03% market value rose $506 million","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APR":1,"CGEM":1,"LABP":1,"LHDX":1,"SANA":1,"GNMK":0.9},"content_text":"北京时间2021年03月15日21时31分，Genmark Diagnostics Inc（GNMK.us）股票出现异动，股价急速上涨29.03%。截至发稿，该股报23.87美元/股，成交量715.309万股，换手率9.79%，振幅0.16%。最近的财报数据显示，该股实现营业收入1.72亿美元，净利润-18.64百万美元，每股收益-0.28美元，毛利67.94百万美元，市盈率-85.25倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Genmark Diagnostics Inc股票所在的医疗器械行业中，整体涨幅为0.56%。其相关个股中，Genmark Diagnostics Inc、Invo Bioscience Inc、Transmedics Group Inc涨幅较大，Genmark Diagnostics Inc、Invo Bioscience Inc、Second Sight Medical Products Inc较为活跃，换手率分别为10.41%、4.93%、3.32%，振幅较大的相关个股有Establishment Labs Hldgs Inc、Second Sight Medical Products Inc、Transmedics Group Inc，振幅分别为9.14%、6.05%、5.36%。Genmark Diagnostics Inc公司简介：GenMark Diagnostics Inc是一家通过检测和测量DNA和RNA靶标来诊断疾病并优化患者治疗的自动化多重分子诊断测试系统的供应商。该公司目前由一个基于其专有的eSensor检测技术的仪器和分子测试进行开发，制造，销售和支持的业务部门运营。该公司的业务和资产位于美国。消息层面，截至21时31分，《罗氏：将以18亿美元收购美国分子诊断测试制造商Genmark Diagnostics》资讯为影响Genmark Diagnostics Inc的重要信息。该信息摘要如下：每经AI快讯，瑞士制药制造商罗氏（Roche）周一表示，将以18亿美元收购美国分子诊断测试制造商Genmark Diagnostics。罗氏表示，将发起收购要约，以全现金交易方式全面收购Genmark，价格为每股24.05美元，较Genmark 2月10日的收盘价溢价43%。（以上内容为自选股智能机器写手Money Call完成，仅作为用户看盘参考，不作为交易依据。）","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.25.1","shortVersion":"4.25.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2119948448"}